• Gilead’s COO retires, shares take a dive pharmafile.
    September 30, 2017
    Gilead has announced that Kevin Young, its Chief Operating Officer, is set to retire from the company in early 2018. The market reacted to the news with apparent surprise, by ducking more than 4% lower on the announcement.
PharmaSources Customer Service